Patients at moderate to high risk of diabetic foot ulcers require medical-grade footwear and should self-monitor foot skin temperatures daily for early signs of ulceration,…
Time-restricted dieting may be better for people with type 2 diabetes to lose weight than counting calories, a US study suggests. Researchers found that people…
One in three adults with NAFLD-related cirrhosis and diabetes in the decade up to 2018 progressed to decompensated cirrhosis, an Australian study shows. Age, hypertension and extrahepatic cancer all…
Patients using GLP-1 receptor agonists for weight loss are nine times more likely to develop pancreatitis than those taking bupropion–naltrexone, Canadian researchers say. Use of…
Diabetes is the most common cause of kidney failure (37% non-Indigenous Australians; 69% Indigenous Australians) and around 50% of people with type 2 diabetes (T2DM)…
The TGA is investigating reports of intestinal obstruction in patients using semaglutide and may consider updating the product information to include a warning about ileus. …
The TGA is once again urging doctors against initiating patients on semaglutide, less than three months after relaxing its prescribing advice, as limited supply struggles…
At age 55, Frankie has multiple health problems. Long-term mental illness has been managed with polypharmacy for many years. Clozapine therapy has contributed to weight…
A proposed PBS crackdown on GLP-1 receptor agonists is inconsistent with type 2 diabetes management guidelines and will force doctors to prescribe less efficacious drugs,…
Novo Nordisk has applied for PBS funding for its subcutaneous weight loss drug Wegovy as a severe obesity treatment. The product contains the GLP-1 receptor…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
